Quantitative analysis of form and function across scales
Advancing skeletal imaging and therapeutics through collaboration and research
Education and Training
We aim to establish quality standards in bone morphometry as an essential research tool and to promote the dissemination of new knowledge, technological advances, and approaches to bone morphometry.
Research and Scholarship
Leadership panels include the ISBM Board of Directors, the ISBM Scientific Leadership Committee, the ISBM Early Career Investigator Committee, and the ISBM Working Groups. The full ISBM Congress is held once every two to three years.
Ready to find out more?
We welcome new members at all levels to join our efforts. Membership can be obtained by registering for and attending one of our in-person congresses of the ISBM. Learn more about the upcoming ISBM 2026 meeting here (July 4-7th, 2026 in London, England). Between meetings, new members can join anytime by registering online.
ISBM News
Dr. Karl Jepsen
Associate Dean for Research
Professor of Orthopaedic Surgery and Biomedical Engineering
University of Michigan
Dr. Annemarie Lang
Assistant Professor, University of Michigan, USA
Dr. David Cooper
Professor, University of Saskatchewan
Dr. Sandrine Soubes
Founder of Tesselle Development
Dr. Drenka Trivanovic
Senior Research Associate, University of Belgrade
Board Member, BMAS
Dr. Hannah Fricke
Brigham and Women’s Hospital
Harvard Medical School
Dr. Eva Wölfel
University of Southern Denmark
Dr. Shatavisha Dasgupta
Broad Institute of MIT and Harvard
Dr. Joseph Wallace and this Bone Biology and Mechanics Laboratory (BBML) at IUPUI are committed to improving our understanding of how the body works through innovative preclinical and clinical research. The lab focuses on bone mechanics (ability to effectively bear loads) and mechanobiology (how cells respond to mechanical stimuli to maintain and/or increase bone mass) in the context of disease and treatment. We investigate bone from mechanical engineering and materials science perspectives by tying morphology and composition to mechanical function and fracture resistance at discrete length scales throughout bone’s rich tissue hierarchy. Our long-term goal is to use combinatorial treatments targeting deficiencies in bone mass/quantity and bone tissue quality in complex disease states that have musculoskeletal complications leading to fragility and fracture. Our current focus is on mechanical and pharmaceutical manipulations in diseases including diabetes and chronic kidney disease.
